Assisting in disease prevention, artificial intelligence takes the lead

Author: admin
Published on: 2023-06-09 15:38
Read: 1
Category: News Information

Big data, the Internet and artificial intelligence are promoting the digitization process of the medical system. The new intelligent and platform based applications will further enhance the quality of medical care and provide personalized solutions for disease prevention.
Scientists, doctors, and engineers have invested considerable time in developing new digital applications. The goal of these tasks is not only to detect diseases in the early stages, but also to achieve disease prevention. Dr. Enise Lauterbach, a cardiologist from Trier, Germany, said, "The diagnosis and treatment of cardiovascular diseases are already very advanced in technology and have saved many lives. If diseases can be prevented, the effect will be even better
Dr. Lauterbach emphasized that "digital healthcare applications can give patients greater self-determination. By understanding their own health data, patients can learn a lot and become responsible experts." As a digital pioneer, she firmly believes that a fully informed and actively involved patient can better manage their own health, rather than just focusing on disease. As introduced by two experts, digitalization of the healthcare system will be a driving factor that can change and improve the lives of many patients. Medical staff and patient relatives can also participate, while reducing the burden through monitoring and remote care. The digitally linked system not only helps to compensate for the shortage of nursing staff in an aging society worldwide, but also improves the level of medical services in underdeveloped rural areas.

Share

Recommended Posts

  • 2024-12-26
    admin
    Biyun Tian was founded in 2001 by international students working and studying at Harvard University. For over 20 years, we have been dedicated to independent research and development as well as production. Established in 2007, Shanghai Biyuntian Biotechnology Co., Ltd. is a national level specialized, refined, unique, and new "Little Giant" enterprise. It was further selected as one of the second batch of national level specialized, refined, unique, and new "Little Giant" enterprises recommended for support in the first year. It is also a Shanghai Science and Technology Little Giant Enterprise, a leading enterprise in the G60 Science and Technology Innovation Corridor, one of the top 100 private enterprises driving science and technology innovation in the Yangtze River Delta G60 Science and Technology Innovation Corridor, a "TOP100" brand value list...
  • 2024-12-26
    admin
    Suzhou Yikesai Biotechnology Co., Ltd., with the mission of "accelerating the application of life sciences and benefiting people's health", is committed to solving the bottleneck of biopharmaceuticals and achieving the localization of key raw materials. It has become one of the excellent enterprises in the upstream core raw materials of biopharmaceuticals in China. The company is a national high-tech enterprise, a national specialized and innovative small giant enterprise, a member of the China International Serum Industry Association (ISIA), and a research center for CD serum-free culture medium engineering in the fields of biopharmaceuticals and cell therapy in Jiangsu Province.The company currently focuses on three major product segments: serum-free culture media, fetal bovine serum, and identification reagents, providing international quality products and servic...
  • 2024-12-26
    admin
    Zhongshan Kangtian Shenghe Biotechnology Co., Ltd. (referred to as "Kangsheng Biotechnology")Overseas ReturneesFounded in April 2018 by Dr. Pan Honghui and several other experts, [2] settled inZhongshan National Health Science and Technology Industry Base——Zhongde (Zhongshan) Biomedical Industry Park is a company that integrates research and development, production, and servicesinternationalizationBiotechnologyThe company. [4] Its core product is applied to proteinsMonoclonal antibodyMedicationsvaccinesDrug development and productionSerum-free culture medium, including chemically restricted culture media, non animal derived culture media [1], and commercially authorizedCHO cellsZhu Development Platform [5]....
  • 返回顶部